Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Swift

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Studies on Alcohol and Drugs|February 9, 2007
Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?Dena Davidson, Suzy Bird Gulliver, Richard Longabaugh, et al.
Drug and Alcohol Dependence|June 14, 2011
Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensorNancy P Barnett, Jennifer Tidey, James G Murphy, et al.
Journal of Studies on Alcohol and Drugs|October 18, 2008
Do patients with alcohol dependence respond to placebo? Results from the COMBINE StudyRoger D Weiss, Stephanie S O'malley, James D Hosking, et al.
Addiction (Abingdon, England)|January 12, 2026
Is toke cheap? Correspondence between cannabis demand and purchase in the laboratoryElizabeth R Aston, Benjamin L Berey, Michael Amlung, et al.
The American Journal of Psychiatry|November 19, 2025
Acute Effects of Cannabis on Alcohol Craving and Consumption: A Randomized Controlled Crossover TrialJane Metrik, Elizabeth R Aston, Rachel L Gunn, et al.
Archives of General Psychiatry|February 6, 2008
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyRaymond F Anton, Gabor Oroszi, Stephanie O'Malley, et al.
Alcoholism, Clinical and Experimental Research|August 11, 2006
Genetic moderators of naltrexone's effects on alcohol cue reactivityJohn E McGeary, Peter M Monti, Damaris J Rohsenow, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2005
The effect of olanzapine on craving and alcohol consumptionKent E Hutchison, Lara Ray, Erica Sandman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 16, 2016
Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacyKarl Mann, Lars Torup, Per Sørensen, et al.
Alcoholism, Clinical and Experimental Research|December 5, 2008
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approachGabor Oroszi, Raymond F Anton, Stephanie O'Malley, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Studies on Alcohol and Drugs|February 9, 2007
Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?Dena Davidson, Suzy Bird Gulliver, Richard Longabaugh, et al.
Drug and Alcohol Dependence|June 14, 2011
Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensorNancy P Barnett, Jennifer Tidey, James G Murphy, et al.
Journal of Studies on Alcohol and Drugs|October 18, 2008
Do patients with alcohol dependence respond to placebo? Results from the COMBINE StudyRoger D Weiss, Stephanie S O'malley, James D Hosking, et al.
Addiction (Abingdon, England)|January 12, 2026
Is toke cheap? Correspondence between cannabis demand and purchase in the laboratoryElizabeth R Aston, Benjamin L Berey, Michael Amlung, et al.
The American Journal of Psychiatry|November 19, 2025
Acute Effects of Cannabis on Alcohol Craving and Consumption: A Randomized Controlled Crossover TrialJane Metrik, Elizabeth R Aston, Rachel L Gunn, et al.
Archives of General Psychiatry|February 6, 2008
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyRaymond F Anton, Gabor Oroszi, Stephanie O'Malley, et al.
Alcoholism, Clinical and Experimental Research|August 11, 2006
Genetic moderators of naltrexone's effects on alcohol cue reactivityJohn E McGeary, Peter M Monti, Damaris J Rohsenow, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2005
The effect of olanzapine on craving and alcohol consumptionKent E Hutchison, Lara Ray, Erica Sandman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 16, 2016
Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacyKarl Mann, Lars Torup, Per Sørensen, et al.
Alcoholism, Clinical and Experimental Research|December 5, 2008
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approachGabor Oroszi, Raymond F Anton, Stephanie O'Malley, et al.
Pageof 4